← Back to Search

Jumpstart Guide for Dementia Care Planning (PICSI-M Trial)

N/A
Recruiting
Led By Erin Kross, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
55 years of age or older
18 years of age or older
Must not have
Without capacity to complete informed consent procedures and without a legal surrogate to enroll them (for the survey component or qualitative interviews)
Physical or mental limitations preventing completion of study materials
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days following randomization
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a way to help clinicians have better conversations with patients and their families to address healthcare goals. It uses a simple guide called the "Jumpstart Guide" to do this.

Who is the study for?
This trial is for patients aged 55+ with memory issues and chronic conditions like cancer, heart failure, or diabetes. It's also for their caregivers who are involved in their care. Participants must speak English and be treated at a UW Medicine clinic. Clinicians from UW Medicine caring for these patients can join too.
What is being tested?
Researchers are testing the 'Jumpstart Guide' to see if it helps clinicians discuss healthcare goals more effectively with patients having memory problems and their families. They'll compare outcomes between those using the guide and those not to measure its impact on communication.
What are the potential side effects?
Since this trial involves communication tools rather than medical treatments, there aren't traditional side effects. However, participants may experience emotional or psychological impacts from discussing sensitive topics about healthcare goals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 55 years old or older.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to give consent and do not have someone to do it for me.
Select...
I do not have physical or mental limitations that prevent me from completing study tasks.
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days following randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days following randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
EHR documentation of Goals of Care discussions
Secondary study objectives
Anxiety

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Jumpstart GuideExperimental Treatment1 Intervention
The Jumpstart Guide is developed using automated methods. It summarizes the presence/absence of POLST, advance directives and DPOA documentation. The Jumpstart Guide also provides tips for conducting discussion about goals of care.
Group II: Usual CareActive Control1 Intervention
Clinicians of patients in the Usual Care arm will not receive a Jumpstart Guide.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,820 Previous Clinical Trials
1,913,473 Total Patients Enrolled
8 Trials studying Asthma
1,141 Patients Enrolled for Asthma
National Institute on Aging (NIA)NIH
1,789 Previous Clinical Trials
28,187,132 Total Patients Enrolled
6 Trials studying Asthma
76,338 Patients Enrolled for Asthma
Erin Kross, MDPrincipal InvestigatorUniversity of Washington
~500 spots leftby Oct 2025